Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Medicine
Medicine publications
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 1-10 of 19 (Search time: 0.002 seconds).
previous
1
2
next
Item hits:
Preview
Issue Date
Title
Author(s)
1995
A direct analysis of FACS-sorted hemopoietic cell fractions using fish
White, D.
;
Hutchins, C.
;
Haylock, D.
;
Turczynowics, S.
;
Bishop, A.
;
To, L.
;
Hughes, T.
;
Juttner, C.
1997
Mobilization of predominantly Philadelphia chromosome-negative blood progenitors using cyclophosphamide and rHUG-CSF in early chronic-phase chronic myeloid leukaemia: correlation with Sokal prognostic index and haematological control.
Hughes, T.
;
Grigg, A.
;
Szer, J.
;
Ho, J.
;
Ma, D.
;
Dale, B.
;
Green, R.
;
Norman, J.
;
Sage, R.
;
Herrmann, R.
;
Cannell, P.
;
Schwarer, A.
;
Taylor, K.
;
Atkinson, K.
;
Arthur, C.
2012
Monitoring disease response in chronic-phase chronic myeloid leukemia: the age of molecular assays?
Yeung, D.
;
Branford, S.
2023
Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention
Shanmuganathan, N.
;
Wadham, C.
;
Shahrin, N.
;
Feng, J.
;
Thomson, D.
;
Wang, P.
;
Saunders, V.
;
Kok, C.H.
;
King, R.M.
;
Kenyon, R.R.
;
Lin, M.
;
Pagani, I.S.
;
Ross, D.M.
;
Yong, A.S.M.
;
Grigg, A.P.
;
Mills, A.K.
;
Schwarer, A.P.
;
Braley, J.
;
Altamura, H.
;
Yeung, D.T.
;
et al.
2021
Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia
Ochi, Y.
;
Yoshida, K.
;
Huang, Y.-J.
;
Kuo, M.-C.
;
Nannya, Y.
;
Sasaki, K.
;
Mitani, K.
;
Hosoya, N.
;
Hiramoto, N.
;
Ishikawa, T.
;
Branford, S.
;
Shanmuganathan, N.
;
Ohyashiki, K.
;
Takahashi, N.
;
Takaku, T.
;
Tsuchiya, S.
;
Kanemura, N.
;
Nakamura, N.
;
Ueda, Y.
;
Yoshihara, S.
;
et al.
2014
Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on front-line imatinib or nilotinib 300 mg twice daily
Hughes, T.
;
Hochhaus, A.
;
Kantarjian, H.
;
Cervantes, F.
;
Guilhot, F.
;
Niederwieser, D.
;
Le Coutre, P.
;
Rosti, G.
;
Ossenkoppele, G.
;
Lobo, C.
;
Shibayama, H.
;
Fan, X.
;
Menssen, H.
;
Kemp, C.
;
Larson, R.
;
Saglio, G.
2016
Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients
Deininger, M.
;
Hodgson, J.
;
Shah, N.
;
Cortes, J.
;
Kim, D.
;
Nicolini, F.
;
Talpaz, M.
;
Baccarani, M.
;
Müller, M.
;
Li, J.
;
Parker, W.
;
Lustgarten, S.
;
Clackson, T.
;
Haluska, F.
;
Guilhot, F.
;
Kantarjian, H.
;
Soverini, S.
;
Hochhaus, A.
;
Hughes, T.
;
Rivera, V.
;
et al.
2015
BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase
Hughes, T.
;
Saglio, G.
;
Quintás-Cardama, A.
;
Mauro, M.
;
Kim, D.
;
Lipton, J.
;
Bradley-Garelik, M.
;
Ukropec, J.
;
Hochhaus, A.
2011
OCT-1 as a determinant of response to antileukemic treatment
Engler, J.
;
Hughes, T.
;
White, D.
2003
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia
O'Brien, S.
;
Guilhot, F.
;
Larson, R.
;
Gathmann, I.
;
Baccarani, M.
;
Cervantes, F.
;
Cornelissen, J.
;
Fischer, T.
;
Hochhaus, A.
;
Hughes, T.
;
Lechner, K.
;
Nielsen, J.
;
Rousselot, P.
;
Reiffers, J.
;
Saglio, G.
;
Shepherd, J.
;
Simonsson, B.
;
Gratwohl, A.
;
Goldman, J.
;
Kantarjian, H.
;
et al.
Discover
Author
16
Hughes, T.
7
Hochhaus, A.
6
Kantarjian, H.
6
Kim, D.
5
Branford, S.
5
et al.
5
Saglio, G.
5
White, D.
4
Baccarani, M.
4
Guilhot, F.
.
next >
Subject
16
Humans
10
Antineoplastic Agents
10
Imatinib Mesylate
9
Piperazines
9
Pyrimidines
8
Benzamides
7
Aged
7
Female
7
Fusion Proteins, bcr-abl
7
Male
.
next >
Date issued
2
2020 - 2023
13
2010 - 2019
2
2000 - 2009
2
1995 - 1999